发明名称 |
A2A ADENOSINE RECEPTOR ANTAGONISTS |
摘要 |
The present invention relates to novel compounds that are A2A adenosine receptor antagonists, and to their use in treating mammals for various disease states, such as obesity, CNS disorders, including the "movement disorders" (Parkinson's disease, Huntington's Chorea, and catelepsy), and cerebral ischemia, excitotoxicity, cognitive and physiological disorders, depression, ADHD, and drug addiction (alcohol, amphetamine, cannabinoids, cocaine, nicotine, and opioids) and to their use in the enhancement of immune response. The invention also relates to methods for the preparation of such compounds, and to pharmaceutical compositions containing them. |
申请公布号 |
WO2007103776(A2) |
申请公布日期 |
2007.09.13 |
申请号 |
WO2007US63143 |
申请日期 |
2007.03.02 |
申请人 |
CV THERAPEUTICS, INC.;ELZEIN, ELFATIH;KALLA, RAO;ZABLOCKI, JEFF;LI, XIAOFEN;PERRY, THAO;KOBAYASHI, TETSUYA;PARKHILL, ERIC |
发明人 |
ELZEIN, ELFATIH;KALLA, RAO;ZABLOCKI, JEFF;LI, XIAOFEN;PERRY, THAO;KOBAYASHI, TETSUYA;PARKHILL, ERIC |
分类号 |
|
主分类号 |
|
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|